Peptide based malaria vaccine development: personal considerations.
Biochemistry Department, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges, Switzerland. [email protected]
- Published Article
Microbes and Infection
- Publication Date
A brief historical account of synthetic peptide approach to malaria vaccine discovery and development, and recent accomplishments is presented. Application of this approach to high-throughput antigen discovery using the genome information is described. The need of a truly global effort and cooperation to defeat malaria is also discussed.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/08/2017 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/17398135